| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.38 | 0.003 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |